Rossari Biotech Limited (ROSSARI) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.031x

Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has a cash flow conversion efficiency ratio of 0.031x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs302.28 Million ≈ $3.27 Million USD) by net assets (Rs9.78 Billion ≈ $105.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ROSSARI net asset quality score to measure how much of total assets are equity-financed.

Rossari Biotech Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Rossari Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Rossari Biotech Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Rossari Biotech Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rossari Biotech Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ACOTEC SCIEN.H. DL-00001 F:7W3	N/A
PETROTAL CORP. F:SER1	0.036x
Solus Advanced Materials Co Ltd KO:336370	0.006x
John Marshall Bancorp Inc NASDAQ:JMSB	0.032x
Rimini Street Inc NASDAQ:RMNI	-0.906x
Scpharmaceuticals Inc NASDAQ:SCPH	0.756x
Omni Bridgeway Ltd AU:OBL	0.027x
Infortrend Technology Inc TW:2495	0.012x

Annual Cash Flow Conversion Efficiency for Rossari Biotech Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Rossari Biotech Limited from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see ROSSARI company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs11.85 Billion ≈ $128.20 Million	Rs1.37 Billion ≈ $14.86 Million	0.116x	+180.84%
2024-03-31	Rs10.48 Billion ≈ $113.31 Million	Rs432.55 Million ≈ $4.68 Million	0.041x	-75.21%
2023-03-31	Rs9.15 Billion ≈ $98.97 Million	Rs1.52 Billion ≈ $16.48 Million	0.167x	+356.69%
2022-03-31	Rs8.05 Billion ≈ $87.08 Million	Rs293.58 Million ≈ $3.17 Million	0.036x	-68.80%
2021-03-31	Rs4.09 Billion ≈ $44.21 Million	Rs477.67 Million ≈ $5.17 Million	0.117x	-38.90%
2020-03-31	Rs2.87 Billion ≈ $31.00 Million	Rs548.28 Million ≈ $5.93 Million	0.191x	-66.73%
2019-03-31	Rs1.24 Billion ≈ $13.39 Million	Rs711.77 Million ≈ $7.70 Million	0.575x	+95.79%
2018-03-31	Rs870.80 Million ≈ $9.42 Million	Rs255.69 Million ≈ $2.77 Million	0.294x	+287.66%
2017-03-31	Rs619.85 Million ≈ $6.70 Million	Rs46.95 Million ≈ $507.75K	0.076x	--

About Rossari Biotech Limited

NSE:ROSSARI India Specialty Chemicals

Market Cap

$304.41 Million

Rs28.15 Billion INR

Market Cap Rank

#14685 Global

#746 in India

Share Price

Rs508.25

Change (1 day)

+0.78%

52-Week Range

Rs378.60 - Rs698.35

All Time High

Rs1568.62